AirSculpt Technologies, Inc. (NASDAQ:AIRS - Get Free Report) major shareholder Jorey Chernett bought 90,000 shares of AirSculpt Technologies stock in a transaction that occurred on Friday, April 3rd. The stock was purchased at an average cost of $2.82 per share, for a total transaction of $253,800.00. Following the purchase, the insider owned 6,933,761 shares of the company's stock, valued at $19,553,206.02. The trade was a 1.32% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Major shareholders that own more than 10% of a company's shares are required to disclose their sales and purchases with the SEC.
Jorey Chernett also recently made the following trade(s):
- On Monday, March 23rd, Jorey Chernett bought 50,000 shares of AirSculpt Technologies stock. The stock was purchased at an average cost of $2.91 per share, for a total transaction of $145,500.00.
- On Friday, March 20th, Jorey Chernett bought 40,000 shares of AirSculpt Technologies stock. The stock was purchased at an average cost of $2.77 per share, for a total transaction of $110,800.00.
- On Thursday, March 19th, Jorey Chernett bought 77,702 shares of AirSculpt Technologies stock. The stock was purchased at an average cost of $2.64 per share, for a total transaction of $205,133.28.
- On Tuesday, March 17th, Jorey Chernett bought 83,000 shares of AirSculpt Technologies stock. The stock was purchased at an average cost of $2.56 per share, for a total transaction of $212,480.00.
- On Monday, March 16th, Jorey Chernett purchased 105,848 shares of AirSculpt Technologies stock. The shares were acquired at an average cost of $2.43 per share, for a total transaction of $257,210.64.
- On Wednesday, March 11th, Jorey Chernett purchased 88,000 shares of AirSculpt Technologies stock. The shares were acquired at an average cost of $2.15 per share, for a total transaction of $189,200.00.
- On Friday, March 6th, Jorey Chernett purchased 45,600 shares of AirSculpt Technologies stock. The shares were acquired at an average cost of $2.00 per share, for a total transaction of $91,200.00.
- On Wednesday, March 4th, Jorey Chernett purchased 30,000 shares of AirSculpt Technologies stock. The shares were acquired at an average cost of $1.87 per share, for a total transaction of $56,100.00.
- On Tuesday, March 3rd, Jorey Chernett purchased 80,000 shares of AirSculpt Technologies stock. The shares were acquired at an average cost of $1.71 per share, for a total transaction of $136,800.00.
AirSculpt Technologies Trading Down 2.2%
AIRS stock opened at $3.10 on Tuesday. The company has a market capitalization of $218.71 million, a PE ratio of -16.31 and a beta of 2.22. AirSculpt Technologies, Inc. has a one year low of $1.51 and a one year high of $12.00. The company's 50 day moving average price is $2.34 and its two-hundred day moving average price is $4.32. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.51 and a current ratio of 0.51.
AirSculpt Technologies (NASDAQ:AIRS - Get Free Report) last announced its quarterly earnings data on Thursday, April 2nd. The company reported $0.02 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.03) by $0.05. The firm had revenue of $33.44 million for the quarter, compared to analysts' expectations of $34.93 million. AirSculpt Technologies had a negative return on equity of 14.30% and a negative net margin of 11.41%.The company's revenue for the quarter was down 14.8% compared to the same quarter last year. During the same period last year, the firm earned ($0.09) earnings per share. As a group, analysts predict that AirSculpt Technologies, Inc. will post -0.01 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
A number of equities analysts have commented on AIRS shares. Wall Street Zen raised AirSculpt Technologies from a "sell" rating to a "hold" rating in a research note on Sunday. Weiss Ratings restated a "sell (d-)" rating on shares of AirSculpt Technologies in a report on Monday, December 29th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Reduce" and a consensus target price of $6.00.
Read Our Latest Analysis on AirSculpt Technologies
Institutional Trading of AirSculpt Technologies
Several large investors have recently added to or reduced their stakes in AIRS. Virtu Financial LLC bought a new stake in AirSculpt Technologies in the fourth quarter valued at $30,000. Millennium Management LLC bought a new stake in AirSculpt Technologies in the fourth quarter valued at $33,000. Aigen Investment Management LP bought a new stake in AirSculpt Technologies in the fourth quarter valued at $36,000. Wells Fargo & Company MN boosted its holdings in AirSculpt Technologies by 49.9% in the fourth quarter. Wells Fargo & Company MN now owns 19,275 shares of the company's stock valued at $38,000 after acquiring an additional 6,420 shares in the last quarter. Finally, BNP Paribas Financial Markets boosted its holdings in AirSculpt Technologies by 239.5% in the third quarter. BNP Paribas Financial Markets now owns 5,952 shares of the company's stock valued at $48,000 after acquiring an additional 4,199 shares in the last quarter. Institutional investors own 91.54% of the company's stock.
About AirSculpt Technologies
(
Get Free Report)
AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company's flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.
Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
